Skip to main content

Table 1 Characteristics of all studies included in the present analysis

From: Prevalence of vancomycin-resistant Enterococci in India between 2000 and 2022: a systematic review and meta-analysis

Authors

Publication year

Study period

Study location by Zonal Council

Study population

Specimen type(s)

AST method(s)

Total Enterococci isolates

Total E. faecalis isolates

Total E. faecium isolates

Total VRE isolates (prevalence %)

E. faecalis VRE

E. faecium VRE

Bhargava et al. [56]

2022

November 2018 to December 2019

Central India

Patients > 5 years presenting with UTI

Urine

Kirby-Bauer disc diffusion

18

-

-

5 (27.78%)

-

-

Bhatt et al. [57]

2015

August 2011 to February 2014

-

In-patients and out-patients at a tertiary care hospital

Bile fluid, blood, CSF,

pus, semen, tracheal aspirate, urine

Kirby-Bauer disc diffusion

200

150

50

28 (14.00%)

6

22

Das et al. [58]

2022

January 2016 to December 2018

Northern India

Patients symptomatic of UTI

Urine

VITEK-2, Kirby-Bauer disc diffusion

118

94

20

20 (16.95%)

14

6

Das et al. [59]

2021

January 2019 to December 2020

Eastern India

Patients ≥ 18 years developing UTI symptoms

Urine

VITEK-2

457

381

76

41 (8.97%)

18

23

Deshpande et al. [60]

2013

-

Western India

-

-

Broth microdilution

291

204

87

57 (19.59%)

38

19

Gangurde et al. [61]

2014

August 2012 to July 2013

Western India

-

-

Vancomycin agar screen test

180

108

58

15 (8.33%)

5

8

Goel et al. [62]

2016

April 2013 to May 2014

Northern India

Out-patients and in-patients < 48 h after hospital admission suspected of UTI

Urine

Kirby-Bauer disc diffusion, Vancomycin agar screen test, MIC by agar dilution

115

61

42

13 (11.30%)

6

5

Hazarika et al. [24]

2021

-

North-eastern India

Healthy individuals from Adi tribes

Stool

Kirby-Bauer disc diffusion

6

-

-

2 (33.33%)

-

-

Jain et al. [63]

2022

January 2014 to June 2015

Northern India

Pregnant women who underwent Caesarean delivery and developed surgical site infection within 30 days

Infected surgical site swab

Kirby-Bauer disc diffusion

9

-

-

3 (33.33%)

-

-

Kapoor et al. [64]

2005

April to October 2001

Northern India

Paediatric in-patients with bacteraemia

Blood

Vancomycin agar screen test, MIC by agar dilution

50

10

33

0 (0.00%)

0

0

Meena et al. [65]

2017

November 2015 to April 2016

Northern India

In-patients and out-patients symptomatic of UTI

Urine

Kirby-Bauer disc diffusion

70

9

61

26 (37.14%)

1

25

Phukan et al. [66]

2016

-

North-eastern India

In-patients and out-patients of a tertiary care hospital

Blood, pus, sputum, throat swabs,

urine

Kirby-Bauer disc diffusion

67

54

13

16 (23.88%)

9

7

Praharaj et al. [67]

2013

November 2008 to October 2009

Southern India

In-patients and out-patients

CSF, peritoneal fluid,

pleural fluid,

pus, synovial fluid,

tissue biopsies,

urine, wound swabs

Kirby-Bauer disc diffusion, Vancomycin agar screen test, MIC by agar dilution

367

-

-

32 (8.72%)

29

0

Purohit et al. [68]

2017

October 2013 to April 2015

Northern India

Hospitalised patients

Blood, pus, urine

MIC by agar dilution, E test

250

82

162

57 (22.80%)

2

55

Sami et al. [69]

2020

March 2018 to February 2019

Central India

In-patients and out-patients of a tertiary care hospital

Pus, urine

Kirby-Bauer disc diffusion, VITEK-2

1014

-

-

31 (3.06%)

1

30

Shinde et al. [70]

2012

-

Western India

In-patients and out-patients of a tertiary care hospital

Blood, body fluids,

pus, urine

Kirby-Bauer disc diffusion

54

47

5

0 (0.00%)

0

0

Sreeja et al. [71]

2012

January to December 2008

Southern India

-

Blood, body fluids,

pus, tissue, urine

Kirby-Bauer disc diffusion, E test

128

97

31

0 (0.00%)

0

0

Taneja et al. [72]

2004

October 2000 to April 2001

Northern India

Patients suspected of UTI

Urine

Vancomycin agar screen test

144

80

17

8 (5.56%)

1

5

Yadav & Agarwal [73]

2022

June 2019 to May 2020

Central India

Patients requiring bacterial culture

Blood, body fluids,

pus, urine

Kirby-Bauer disc diffusion

145

73

69

14 (9.66%)

4

9

  1. Note: ‘-’ means data was not disclosed. AST = antimicrobial susceptibility testing, VRE = vancomycin-resistant Enterococci, UTI = urinary tract infection, MIC = minimum inhibitory concentration, CSF = cerebrospinal fluid